Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIG | 54.0 | 59 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | MIG | 47.0 | 45 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIG | 81.0 | 60 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | MIG | 64.0 | 71 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIG | 78.0 | 71 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | MIG | 69.0 | 53 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 30.0 | 62 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 46.0 | 67 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 40.0 | 78 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 47.0 | 76 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 37.5 | 88 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 100.0 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 70.5 | 62 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | MIG | 65.0 | 74 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 65.0 | 63 | |
N2645 | TNF-a | 100 | ng/mL | 4 | MIG | 60.0 | 75 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 166.5 | 56 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | MIG | 142.0 | 45 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIG | 29.0 | 42 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | MIG | 19.0 | 59 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIG | 17.0 | 68 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | MIG | 19.0 | 73 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIG | 26.0 | 70 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | MIG | 30.0 | 65 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | MIG | 24.0 | 53 |